Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eloxx Pharmaceuticals
Biotech
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Almirall is handing over $3 million for Eloxx Pharmaceuticals’ molecule for a pair of rare skin diseases just before the drug enters the clinic.
James Waldron
Mar 13, 2024 10:31am
Eloxx stock slumps lower on failed phase 2 cystic fibrosis trial
Sep 15, 2022 5:40am
Eloxx ends long wait for cystic fibrosis data. Market shrugs
Nov 17, 2021 8:15am
BeiGene bumps up Wang to financial chief—Chutes & Ladders
Apr 2, 2021 9:30am
Eloxx nabs early-stage biotech Zikani Therapeutics, replaces CEO
Apr 1, 2021 9:30am
Viatris appoints Pfizer CFO Narula to C-suite—Chutes & Ladders
Feb 28, 2020 9:30am
